Dear Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust,

I would be very grateful if you could please answer these questions in relation to cancer treatment.

1) Over the last 6 months, how many patients were treated with a combination of Dabrafenib + Trametinib for the following diseases:
A) Metastatic Melanoma
B) Adjuvant Melanoma
C) BRAF mutated Lung Cancer

2) Over the last 6 months, how many patients were treated with a combination of Encorafenib (Braftovi) + Binimetnib (Mektovi) for the following diseases:
A) Metastatic Melanoma
B) Colorectal Cancer
C) Any other indications

I'd like to sincerely thank you for taking the time to answer these questions

Yours faithfully,
Oliver Caswell

Dear WRAITH, Diane (DONCASTER AND BASSETLAW TEACHING HOSPITALS NHS FOUNDATION TRUST),

Thank you for your response. Unfortunately the attachment is not opening. Is there any other way to send the information?

Thank you for your cooperation.

Yours sincerely,

Oliver Caswell

Dear WRAITH, Diane (DONCASTER AND BASSETLAW TEACHING HOSPITALS NHS FOUNDATION TRUST),

Apologies, the attachment has now loaded, no further action required. Thank you again for your cooperation.

Yours sincerely,

Oliver Caswell